Skip to main content

Table 1 Baseline demographic information and drug use or vaccination characteristics

From: The effects of Chinese proprietary medicine and vaccination on patients with COVID-19: a retrospective study in Macao

Characteristics

Population

No. of participants (n (%))

976

Gender (n (%))

 Male

468 (47.9%)

 Female

508 (52.0%)

 Age (year, mean ± SD)

38.34 ± 15.63

 BMI (kg/m2, median (IQR))

22.4 (20.0, 24.9)

Occupation (n (%))

 Office employee

152 (15.5%)

 Craftsperson

202 (20.2%)

 Service employee

311 (31.8%)

 Healthcare staff

124 (12.7%)

 Unemployed or retired person

20 (2.0%)

 Student

111 (11.3%)

 Others

56 (5.7%)

Region (n [%])

 Macao (China) native

643 (65.8%)

 Chinese mainland

150 (15.3%)

 Others

183 (18.7%)

 Smoker {[n (%)]}

182 (18.6%)

Alcohol consumer {[n (%)]}

332 (34.0%)

Physical exercise [n (%)]

 Never

328 (33.6%)

 Seldom

230 (23.5%)

  < 3 times per week

194 (19.8%)

  ≥ 3 times per week

213 (21.8%)

Stimulating diet preference [n (%)]

581 (59.5%)

Vaccination history [n (%)]

 Unvaccinated

121 (12.3%)

 Partially vaccinated

421 (43.1%)

 Fully vaccinated

434 (44.4%)

 No. of days from last time (median (IQR))

141.0 (89.0, 230.0)

Vaccine product [n (%)]

 CNBG

729 (74.6%)

 mRNA

82 (8.4%)

 CNBG double times and mRNA

42 (4.3%)

 mRNA double times and CNBG

2 (0.2%)

Medical treatment (frequency, [n (%)]

 Lianhua Qingwen capsule

899 (92.1%)

 Huoxiang Zhengqi capsule

214 (21.9%)

Duration of medicating [n (%)]

 Forget

26 (2.6%)

 0

21 (2.1%)

 1–6 days

378 (38.7%)

 7–12 days

367 (37.6%)

  > 12 days

184 (18.8%)